THE MULTIDRUG RESISTANCE PHENOTYPE

[21] KERR DJ, 1986, CANCER CHEMOTH PHARM, V18, P239

[22] LOHS WD, 1988, CANCER RES, V48, P3025

[23] MA DDF, 1987, LANCET, V1, P135

[24] MARSH W, 1987, CANCER RES, V47, P5080

[25] MERRY S, 1987, BRIT J CANCER, V56, P185

[26] POMMIER Y, 1986, CANCER RES, V46, P3075

[27] AMPLIFICATION OF P-GLYCOPROTEIN GENES IN MULTIDRUG-RESISTANT MAMMALIAN-CELL LINES [J]. NATURE, 1985, 316 (6031) : 817 - 819

[28] SAFA AR, 1986, J BIOL CHEM, V261, P6137

[29] POTENTIATION OF DOXORUBICIN CYTO-TOXICITY BY THE CALCIUM-ANTAGONIST BEPRIDIL IN ANTHRACYCLINE-RESISTANT AND ANTHRACYCLINE-SENSITIVE CELL-LINES - A COMPARISON WITH VERAPAMIL [J]. CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1987, 20 (04) : 285 - 290

[30] SEEBER S, 1982, CANCER RES, V42, P4719

[21] KERR DJ, 1986, CANCER CHEMOTH PHARM, V18, P239

[22] LOHS WD, 1988, CANCER RES, V48, P3025

[23] MA DDF, 1987, LANCET, V1, P135

[24] MARSH W, 1987, CANCER RES, V47, P5080

[25] MERRY S, 1987, BRIT J CANCER, V56, P185

[26] POMMIER Y, 1986, CANCER RES, V46, P3075

[27] AMPLIFICATION OF P-GLYCOPROTEIN GENES IN MULTIDRUG-RESISTANT MAMMALIAN-CELL LINES [J]. NATURE, 1985, 316 (6031) : 817 - 819

[28] SAFA AR, 1986, J BIOL CHEM, V261, P6137

[29] POTENTIATION OF DOXORUBICIN CYTO-TOXICITY BY THE CALCIUM-ANTAGONIST BEPRIDIL IN ANTHRACYCLINE-RESISTANT AND ANTHRACYCLINE-SENSITIVE CELL-LINES - A COMPARISON WITH VERAPAMIL [J]. CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1987, 20 (04) : 285 - 290

[30] SEEBER S, 1982, CANCER RES, V42, P4719